Objective Systolic Function Recuperation Assessed by Echocardiography
NCT ID: NCT01086124
Last Updated: 2013-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
42 participants
OBSERVATIONAL
2010-03-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Myocardial Infarction Quality Assurance Project
NCT02399891
Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
NCT01202045
Left Ventricular Function After Primary Percutaneous Coronary Intervention: Role of Speckle Echocardiography
NCT04103008
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
NCT00539045
Strain Echo in Acute Heart Failure
NCT02371642
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Echocardiography 1 month
Patients will all have an echocardiography 1 month post myocardial infarction and 3 months post myocardial infarction
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ST elevation myocardial infarction treated with primary PCI
* Anterior or apical akinesis and left ventricular ejection fraction ≤ 45% on early echocardiography (48hours - 7 days post myocardial infarction)
* Initial ECG showing at least 1 mm ST elevation in 2 leads corresponding to the same vascular territory
Exclusion Criteria
* Left bundle branch block
* Vital prognosis less than 6 months
* Cardiogenic shock
* Rescue PCI
* Sub-optimal echocardiographic imaging (contrast use is allowed)
* Significant valvular heart disease (moderate or severe)
* Surgical revascularization
* Pregnancy or breastfeeding
* Incapacity to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Paul Farand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Paul Farand
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Farand, md
Role: PRINCIPAL_INVESTIGATOR
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.